The role of population PK–PD modelling in paediatric clinical research
✍ Scribed by Roosmarijn F. W. De Cock; Chiara Piana; Elke H. J. Krekels; Meindert Danhof; Karel Allegaert; Catherijne A. J. Knibbe
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 340 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND. Providers play a vital role in the successful recruitment of underrepresented patients to cancer clinical trials because they often introduce the opportunity of clinical trials. The purpose of the current systematic review was to describe provider‐related factors influen
The population risk, for example the control group mortality rate, is an aggregate measurement of many important attributes of a clinical trial, such as the general health of the patients treated and the experience of the staff performing the trial. Plotting measurements of the population risk again